Skip to content
★ Sign in to follow
DE

David E. Nelson

Sanguine Corp
Total declarations
11
Company
1
▲ Purchases (1 ops.)
€26k
▼ Sales (0 ops.)
—

Latest filing published 21 Mar 2011 for SANGUINE CORP.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

David E. Nelson: trading record in brief

All filings by David E. Nelson on record concern Sanguine Corp. Between 7 October 2005 and 31 December 2010, the trades on record add up to 11 filings.

Purchases make up the whole of the open-market record (1 purchase, €26k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 10 share grants.

Most recently, on 21 March 2011, the filings show a share grant in Sanguine Corp. The last purchase on record was published on 16 June 2008, which is 6,720 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David E. Nelson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◆
    Chief Financial OfficerExecutivesSanguine Corp
    0SEC
    2,500 shares0Common StockSEC:0001010412-11-000102:0
  • ◆
    Chief Financial OfficerExecutivesSanguine Corp
    0SEC
    7,500 shares0Common StockSEC:0001010412-11-000102:1
  • ▲
    Chief Financial OfficerExecutivesSanguine Corp
    40,000 USD0SEC
    1,000,000 shares@ US$0.04Common StockSEC:0001137892-08-000018:0
    Canonical exit: 10 Sept 2008 (T+90)
  • ◆
    Chief Financial OfficerExecutivesSanguine Corp
    2,750 USD0SEC
    25,000 shares@ US$0.11Common StockSEC:0001137892-08-000006:0
  • ◆
    Chief Financial OfficerExecutivesSanguine Corp
    2,750 USD0SEC
    25,000 shares@ US$0.11Common StockSEC:0001137892-08-000006:1
  • ◆
    Chief Financial OfficerExecutivesSanguine Corp
    3,750 USD0SEC
    37,500 shares@ US$0.10Common StockSEC:0001137892-08-000006:2
  • ◆
    Chief Financial OfficerExecutivesSanguine Corp
    3,000 USD0SEC
    50,000 shares@ US$0.06Common StockSEC:0001137892-08-000006:3

7 of 7 declarations